Evidence map›Paper›PMID 36111502›Full record

ArticleMolecular medicine reports2022

Rubiscolin‑6 rapidly suppresses the postprandial motility of the gastric antrum and subsequently increases food intake via δ‑opioid receptors in mice.

Koji Ataka, Akihiro Asakawa, Ikuo Kato

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Association ofJournal of clinical medicine · 2024
    Article
  3. CoexpressedMolecular pharmacology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Koji AtakaLaboratory of Medical Biochemistry, Kobe Pharmaceutical University, Kobe 658‑8558, Japan.
Akihiro AsakawaDepartment of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890‑8544, Japan.
Ikuo KatoLaboratory of Medical Biochemistry, Kobe Pharmaceutical University, Kobe 658‑8558, Japan.
Kobe Pharmaceutical University · JPKagoshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rubiscolin‑6 is a food‑derived opioid peptide found in

Indexed as

Anti-Anxiety AgentsPyloric AntrumAnimalsEatingMaleMiceMice, Inbred C57BLNarcotic AntagonistsOpioid PeptidesPeptide FragmentsReceptors, OpioidRibulose-Bisphosphate CarboxylaseAnti-Anxiety AgentsNarcotic AntagonistsOpioid PeptidesPeptide FragmentsReceptors, OpioidRibulose-Bisphosphate Carboxylaserubiscolin 6eating behaviormanometric methodpostprandial motilitystomachδ‑opioid receptor agonist

Identifiers

PMID36111502
PMCPMC9494588
OpenAlexW4295945874

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.